← All organizations

Guangzhou Trinomab Biotech Co., Ltd.

Government

Also known as: Trinomab Biotech Co., Ltd. | Zhuhai Trinomab Pharmaceutical Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 30, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (8 distinct, 12 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (15)

NCT06710925Lead sponsorPhase 3Nov 30, 2024
NCT06083623Study directorPhase 2/Phase 3Oct 6, 2023
NCT06083623Lead sponsorPhase 2/Phase 3Oct 6, 2023
NCT06083623OfficialPhase 2/Phase 3Oct 6, 2023
NCT06068608Lead sponsorPhase 1Oct 5, 2023
NCT05664750Lead sponsorPhase 3Dec 31, 2022
NCT05664750Study directorPhase 3Dec 31, 2022
NCT05630573Lead sponsorPhase 1/Phase 2Oct 25, 2022
NCT06607380Lead sponsorPhase 1Aug 13, 2022
NCT05625477Lead sponsorPhase 2Apr 18, 2022
NCT05842798Lead sponsorPhase 1Oct 15, 2021
NCT04629131Lead sponsorPhase 1Nov 25, 2020
NCT02808416CollaboratorPhase 1/Phase 2Jun 1, 2016
NCT02808364CollaboratorPhase 1/Phase 2Jun 1, 2016
NCT02709616CollaboratorPhase 1/Phase 2Mar 1, 2016

Details

Last known activity: Nov 30, 2024